DexCom, Inc. (DXCM): Price and Financial Metrics

DexCom, Inc. (DXCM)

Today's Latest Price: $407.35 USD

7.14 (1.78%)

Updated Jul 2 4:00pm

Add DXCM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

DXCM Stock Summary

  • DXCM has a higher market value than 95.08% of US stocks; more precisely, its current market capitalization is $37,436,613,541.
  • With a price/earnings ratio of 253.12, Dexcom Inc P/E ratio is greater than that of about 98.4% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Dexcom Inc is higher than 97.48% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Dexcom Inc, a group of peers worth examining would be SQ, BMRN, IAC, ANSS, and ILMN.
  • DXCM's SEC filings can be seen here. And to visit Dexcom Inc's official web site, go to
DXCM Daily Price Range
DXCM 52-Week Price Range

DXCM Stock Price Chart Technical Analysis Charts

DXCM Price/Volume Stats

Current price $407.35 52-week high $428.59
Prev. close $400.21 52-week low $138.28
Day low $398.06 Volume 1,082,126
Day high $415.47 Avg. volume 1,496,501
50-day MA $381.73 Dividend yield N/A
200-day MA $261.50 Market Cap 37.62B

DexCom, Inc. (DXCM) Company Bio

DexCom focuses on the design, development, and commercialization of continuous glucose monitoring systems for patients with diabetes. The company was founded in 1999 and is based in San Diego, California.

DXCM Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for DXCM, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Dexcom Inc ranked in the 32th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 47%. As for the metrics that stood out in our discounted cash flow analysis of Dexcom Inc, consider:

  • The compound growth rate in the free cash flow of Dexcom Inc over the past 5.48 years is 0.77%; that's better than 84.57% of cash flow producing equities in the Healthcare sector, where it is classified.
  • 97% of the company's capital comes from equity, which is greater than 89.85% of stocks in our cash flow based forecasting set.
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 10.11% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Dexcom Inc? See XRAY, CAH, BIO, JNJ, and PDEX.

DXCM Latest News Stream

Event/TimeNews Detail
Loading, please wait...

DXCM Latest Social Stream

Loading social stream, please wait...

View Full DXCM Social Stream

Latest DXCM News From Around the Web

Below are the latest news stories about Dexcom Inc that investors may wish to consider to help them evaluate DXCM as an investment opportunity.

Dow Jones' Strength Wavers Due To Recent Rise In Coronavirus Cases; Growth Stocks Lead Market

The Dow Jones traded near break-even as the S&P; 500 and Nasdaq gained strength in heavy volume. A handful of Leaderboard stocks also traded in buy zones.

Yahoo | July 1, 2020

Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report?

DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 1, 2020

If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now

Dexcom (NASDAQ: DXCM) went public on April 14, 2005. At that price, an investment of $1,000 would have gotten you 82 shares. It consisted of a tiny device inserted under the skin of a diabetes patient.

Yahoo | July 1, 2020

DexCom to redeem convertible debt due 2022

DexCom (DXCM) has issued a notice of redemption to holders of its outstanding 0.75% senior convertible notes due 2022. It will redeem the notes at a cash price of 100% of the principal amount plus accrued and unpaid interest.Prior to the redemption date, holders may convert into DexCom common stock...

Seeking Alpha | June 30, 2020

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, DexCom (DXCM) closed at $405.40, marking a +1.81% move from the previous day.

Yahoo Finance | June 30, 2020

Read More 'DXCM' Stories Here

DXCM Price Returns

1-mo 18.12%
3-mo 56.22%
6-mo 80.25%
1-year 177.13%
3-year 456.79%
5-year 411.04%
YTD 86.23%
2019 82.59%
2018 108.75%
2017 -3.87%
2016 -27.11%
2015 48.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9181 seconds.